These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 604121)

  • 1. A mouse model of influenza protection.
    Russell SM
    Dev Biol Stand; 1977 Jun 1-3; 39():397-403. PubMed ID: 604121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition.
    Reuman PD; Kris RM; Ayoub EM; Small PA
    Microbios; 1988; 54(220-221):135-47. PubMed ID: 2846987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
    Kris RM; Asofsky R; Evans CB; Small PA
    J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host defenses against influenza virus: the role of anti-hemagglutinin antibody.
    Virelizier JL
    J Immunol; 1975 Aug; 115(2):434-9. PubMed ID: 807637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus.
    Floc'h F; Werner GH
    Ann Microbiol (Paris); 1978; 129(4):509-24. PubMed ID: 308787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.
    Quan FS; Compans RW; Cho YK; Kang SM
    Vaccine; 2007 Jan; 25(2):272-82. PubMed ID: 16945454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cell mediated immunity in influenza virus infection in mice.
    Schulman JL; Petigrow C; Woodruff J
    Dev Biol Stand; 1977 Jun 1-3; 39():385-90. PubMed ID: 304820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
    Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K
    J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts.
    Mumcuoglu M; Zakay-Rones Z; Parag G; Weiss L; Slavin S
    Bone Marrow Transplant; 1987 Dec; 2(4):403-12. PubMed ID: 3332187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal-infant transfer of influenza-specific immunity in the mouse.
    Reuman PD; Paganini CM; Ayoub EM; Small PA
    J Immunol; 1983 Feb; 130(2):932-6. PubMed ID: 6848601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of regulator cells induced by the influenza virus in adoptive transfer].
    Volgarev AP; Maĭorova LP; Smorodintsev AA
    Biull Eksp Biol Med; 1987 Jan; 103(1):83-6. PubMed ID: 2879578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody.
    Wong JP; Stadnyk LL; Saravolac EG
    Immunology; 1994 Feb; 81(2):280-4. PubMed ID: 8157277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.
    Tite JP; Hughes-Jenkins C; O'Callaghan D; Dougan G; Russell SM; Gao XM; Liew FY
    Immunology; 1990 Oct; 71(2):202-7. PubMed ID: 2172156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
    Lightman S; Cobbold S; Waldmann H; Askonas BA
    Immunology; 1987 Sep; 62(1):139-44. PubMed ID: 2820868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon and humoral immune response in experimental influenza. I. Infection with virus unadapted to the mouse.
    Szalaty H; Szulc B
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):503-8. PubMed ID: 749803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from a viral respiratory tract infection. IV. Specificity of protection by cytotoxic T lymphocytes.
    Wells MA; Daniel S; Djeu JY; Kiley SC; Ennis FA
    J Immunol; 1983 Jun; 130(6):2908-14. PubMed ID: 6189904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.